Sun Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM, and what generic alternatives to SUN PHARM drugs are available?
SUN PHARM has five hundred and thirty-four approved drugs.
There are thirty-one US patents protecting SUN PHARM drugs.
There are three hundred and fifty-nine patent family members on SUN PHARM drugs in fifty-seven countries and five hundred and forty-one supplementary protection certificates in nineteen countries.
Summary for Sun Pharm
| International Patents: | 359 |
| US Patents: | 31 |
| Tradenames: | 345 |
| Ingredients: | 319 |
| NDAs: | 534 |
| Patent Litigation for Sun Pharm: | See patent lawsuits for Sun Pharm |
| PTAB Cases with Sun Pharm as petitioner: | See PTAB cases with Sun Pharm as petitioner |
Drugs and US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 207008-002 | Oct 11, 2018 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Sun Pharm Inds | OLANZAPINE | olanzapine | TABLET;ORAL | 091038-003 | Apr 23, 2012 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Sun Pharm | TRAMADOL HYDROCHLORIDE | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091607-003 | Dec 30, 2011 | AB2 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Sun Pharm Industries | CARVEDILOL PHOSPHATE | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 090132-003 | Oct 25, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Sun Pharm | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 090492-001 | Oct 28, 2011 | AB3 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | BACTRIM | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 018374-001 | Approved Prior to Jan 1, 1982 | RE28636 | See Plans and Pricing |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-006 | Aug 15, 2014 | 8,952,064 | See Plans and Pricing |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-002 | May 25, 2012 | 8,367,102 | See Plans and Pricing |
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | 8,952,064 | See Plans and Pricing |
| Sun Pharm Industries | BACTRIM DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-002 | Approved Prior to Jan 1, 1982 | RE28636 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 125 mg | ➤ Subscribe | 2018-07-23 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for Sun Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Lithuania | C2021328 | See Plans and Pricing |
| European Patent Office | 2503005 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2014062817 | See Plans and Pricing |
| Russian Federation | 2413718 | See Plans and Pricing |
| Brazil | 112015008951 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1261586 | 12C0028 | France | See Plans and Pricing | PRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124 |
| 0957929 | SPC/GB06/021 | United Kingdom | See Plans and Pricing | PRODUCT NAME: PEGAPTANIB, PREFERABLY IN THE FORM OF ITS SODIUM SALT; REGISTERED: UK EU/1/05/325/001 20060201 |
| 0627406 | 11C0021 | France | See Plans and Pricing | PRODUCT NAME: FINGOLIMOD ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES EN PARTICULIER SON CHLORHYDRATE; REGISTRATION NO/DATE: EU/1/11/677/001 20110317 |
| 0145340 | 99C0005 | Belgium | See Plans and Pricing | PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204 |
| 1255752 | 5/2008 | Austria | See Plans and Pricing | PRODUCT NAME: SUNITINIB, GEGEBENENFALLS IN DER FORM EINES PHARMAZEUTISCH VERTRAEGLICHEN SALZES, EINSCHLIESSLICH DES L-MALAT-SALZES; REGISTRATION NO/DATE: EU/1/06/347/001- EU/1/06/347/003 20060719 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
